Literature DB >> 1715337

In vitro anti-human immunodeficiency virus type 1 activity of biliverdin, a bile pigment.

H Mori1, T Otake, M Morimoto, N Ueba, N Kunita, T Nakagami, N Yamasaki, S Taji.   

Abstract

Biliverdin (BV) is a bile pigment having anti-allergic properties. We examined the effect of BV on human immunodeficiency virus type 1 (HIV-1) in vitro. BV completely inhibited the cytopathic effect of HIV-1 in MT-4 cells at concentrations of 22.2 micrograms/ml or more. This inhibitory effect was also observed when BV was present during the adsorption period of HIV-1. However, BV was cytotoxic to MT-4 cells at concentrations above 800 micrograms/ml. At a concentration of 66.7 micrograms/ml, BV completely inhibited syncytia formation by HIV-infected and uninfected MOLT-4 cells. Moreover, after exposure of HIV-1 particles to BV for 2 h, the infectivity of the virus was reduced in a dose-dependent manner. It is speculated that the anti-HIV activity of BV is due to direct inactivation of virions and inhibition of virus binding to target cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1715337      PMCID: PMC5918533          DOI: 10.1111/j.1349-7006.1991.tb02698.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


human immunodeficiency virus type 1 biliverdin
  5 in total

1.  Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.

Authors:  S Harada; Y Koyanagi; N Yamamoto
Journal:  Science       Date:  1985-08-09       Impact factor: 47.728

2.  Sensitive reverse transcriptase assay to detect and quantitate human immunodeficiency virus.

Authors:  M H Lee; K Sano; F E Morales; D T Imagawa
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

3.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

4.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

5.  Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.

Authors:  J A Levy; A D Hoffman; S M Kramer; J A Landis; J M Shimabukuro; L S Oshiro
Journal:  Science       Date:  1984-08-24       Impact factor: 47.728

  5 in total
  3 in total

1.  Bilitrienones from the chemical oxidation of dodecasubstituted porphyrins.

Authors:  Owendi Ongayi; M Graça H Vicente; Brahma Ghosh; Frank R Fronczek; Kevin M Smith
Journal:  Tetrahedron       Date:  2010-01-01       Impact factor: 2.457

2.  Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro.

Authors:  F McPhee; P S Caldera; G W Bemis; A F McDonagh; I D Kuntz; C S Craik
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

3.  Bilirubin: An Endogenous Molecule with Antiviral Activity in vitro.

Authors:  Rosaria Santangelo; Cesare Mancuso; Simona Marchetti; Enrico Di Stasio; Giovambattista Pani; Giovanni Fadda
Journal:  Front Pharmacol       Date:  2012-03-09       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.